25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS)
09.09.2009 - 12.09.2009
Please select a day:
09.09.2009
10.09.2009
11.09.2009
12.09.2009
Search
Personal programme
Please enter your email address here in order to bring up your personal programme



Home


Friday, September 11, 2009

- Click on a checkbox to select a whole session.
- Session titles which are underlined can be clicked upon to show further details.
- Individual programme items can also be selected.
- Go to another day to select further points or click on display to show your saved personal programme.
08:00 Emerging insights: assessment and management of symptoms in multiple sclerosis (Acorda Therapeutics Satellite)
09:15 Charcot Award Lecture (Plenary Session 2)
10:45 Neutralising antibodies to IFN-beta (Parallel Session 7)
10:45 Advances in therapy II (Parallel Session 8)
10:45 MR assessment of disability (Parallel Session 9)
12:45 Redefining success in MS: challenging treatment expectations (Biogen Idec & Elan Satellite)
14:00 Neuroprotection and repair (Parallel Session 10)
14:00 Cognition (Parallel Session 11)
14:00 PML – pathogenesis and new therapies (Parallel Session 12)
15:30 MS variants - 2 (Poster topic 19)
15:30 Epidemiology - 2 (Poster topic 20)
15:30 MS symptoms - 2 (Poster topic 21)
15:30 Neuro-ophthalmology (Poster topic 22)
15:30 Pathology of MS (Poster topic 23)
15:30 Experimental models - 2 (Poster topic 24)
15:30 Genetics / transcriptomics - 2 (Poster topic 25)
15:30 Immunology - 2 (Poster topic 26)
15:30 Biomarkers (Poster topic 27)
15:30 Neurobiology - 2 (Poster topic 28)
15:30 Imaging - 2 (Poster topic 29)
15:30 Neurophysiology (Poster topic 30)
15:30 Neuropsychology and fatigue - 2 (Poster topic 31)
15:30 Immunomodulation - 2 (Poster topic 32)
15:30 Immunosuppression (Poster topic 33)
15:30 Treatment of specific symptoms (Poster topic 34)
15:30 Comprehensive care and rehabilitation - 2 (Poster topic 35)
15:30 Quality of life (Poster topic 36)
15:30 Late breaking news (Poster topic 37)
17:00 Cytotoxic T cells in MS (Hot Topics in MS 4)
17:00 Risks of immunotherapeutic interventions (Hot Topics in MS 5)
17:00 Energy metabolism (Hot Topics in MS 6)
18:00 Cladribine tablets – a potential new short-course oral therapy in MS (Merck Serono Satellite)
19:15 Alemtuzumab: exploring a new treatment approach for MS (Genzyme & Bayer Schering Sat.)